Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking
Authors:
- Yonglan LiuYLYonglan Liu
- Bozhi ShiBSBozhi Shi
- Yueting LiYLYueting Li
- Guixue WangGWGuixue Wang
- Guizhao LiangGLGuizhao Liang
- 1 September 2013
- journal article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 45, 65-83
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Developing β‐secretase inhibitors for treatment of Alzheimer’s diseaseJournal of Neurochemistry, 2011
- Therapies for Alzheimer's diseaseNature Reviews Drug Discovery, 2007
- Alzheimer disease: progress or profit?Nature Medicine, 2006
- Spotlight on BACE: The secretases as targets for treatment in Alzheimer diseaseJournal of Clinical Investigation, 2001
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsHuman Molecular Genetics, 2001
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generationNature Neuroscience, 2001
- The tangled tale of tauNature, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Cleavage of Amyloid β Peptide During Constitutive Processing of Its PrecursorScience, 1990